Clinical Trial

The Study of Efficacy and Safety of Dimephosphon® in Acute Ischemic Stroke

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated September 11, 2025 (before its estimated January 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of Dimephosphon® in acute ischemic stroke
Trial Details
NCT Number NCT07167550
Lead Sponsor Tatchempharmpreparaty, JSC
Conditions Stroke, Acute Stroke, Ischemic Stroke, Cerebrovascular Disorders, Physiological Effects of Drugs
Enrollment 184 participants
Start Date 2025-09-06
Primary Completion 2026-01-31 (estimated)
Study Completion 2026-04-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-11